T0	Participants 141 192	subgroups with glucocorticoid-induced osteoporosis.
T1	Participants 305 366	different subgroups with glucocorticoid-induced osteoporosis.
T2	Participants 580 607	patients on glucocorticoids
T3	Participants 744 771	different patient subgroups
T4	Participants 869 877	Patients
T5	Participants 1063 1292	subpopulations]were subgrouped by age; gender; menopausal status in women; dose and duration of prednisone during the trial; and baseline serum 25-OH vitamin D, LS BMD T-score, creatinine clearance, and concomitant medication use
T6	Participants 1869 1873	BMD.
T7	Participants 1874 1895	Osteoporotic patients